Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01892215
Other study ID # MHST2012-08
Secondary ID
Status Completed
Phase N/A
First received June 30, 2013
Last updated June 20, 2017
Start date October 2012
Est. completion date June 2013

Study information

Verified date June 2017
Source Saint Thomas Hospital, Panama
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Obstetrical blood loss is an important reason of maternal morbidity and mortality. Because of the increase in the rate of cesarean section, any procedure that could help reduce blood loss during cesarean section should be investigated. The purpose of this study was to compare 2 methods of blunt expansion of the uterine incision at the time of cesarean delivery: transversal vs. cephalad-caudad.


Recruitment information / eligibility

Status Completed
Enrollment 839
Est. completion date June 2013
Est. primary completion date May 2013
Accepts healthy volunteers No
Gender Female
Age group N/A and older
Eligibility Inclusion Criteria:

- Singleton pregnancies

- Gestational age: 34 weeks or more

- Delivery by cesarean section

- Presurgical hemoglobin > 10.5 g/dL

Exclusion Criteria:

- Two or more previous cesarean sections

- History of uterine rupture in a previous pregnancy

- History of myomectomy

- History of abdominal trauma with an uterine lesion

- Blood dyscrasia

- Multiple pregnancy

- Placenta previa

- Abruptio placenta

- Stillbirth

- Sharp uterine expansion

Study Design


Related Conditions & MeSH terms

  • Blunt Expansion of the Uterine Incision

Intervention

Procedure:
Cephalad-caudad expansion
Blunt expansion of the uterine incision by the physician separating the fingers in a cephalad-caudad direction.
Transversal expansion
Blunt expansion of the uterine incision by the physician separating the fingers in a transversal direction.

Locations

Country Name City State
Panama Saint Thomas Maternity Hospital Panama

Sponsors (1)

Lead Sponsor Collaborator
Saint Thomas Hospital, Panama

Country where clinical trial is conducted

Panama, 

Outcome

Type Measure Description Time frame Safety issue
Primary Blood loss (hemoglobin level) Difference in hemoglobin level between 24 hours pre-surgery and the hemoglobin level before leaving the hospital. 72 hours
Secondary Surgical complications Number of cases of surgical complications (hematomas, unintended extension of the uterine incision, need for transfusion) between the two techniques. 72 hours
Secondary Unintented extension of uterine incision Number of cases of unintended extension of the uterine incision during surgery between the two techniques. 72 hours
Secondary Hematoma formation Number of cases of hematoma formation during or after between the two techniques. 72 hours
Secondary Need for transfusion Number of cases that required a blood transfusion between the two techniques. 72 hours